InvestorsHub Logo
Followers 70
Posts 7727
Boards Moderated 0
Alias Born 01/10/2014

Re: Citrati post# 11156

Tuesday, 12/19/2023 2:20:00 PM

Tuesday, December 19, 2023 2:20:00 PM

Post# of 11446
I think Anavex will take a licensing approach to AD, PD/PDD and keep rare diseases in house. Same thoughts I had 8 years ago.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.